Report · Health plans & employers · August 2026

Find the functional GI care gap hiding in repeat care.

Functional GI conditions can hide across diagnoses, symptom claims, investigations, medication changes and repeat episodes of care. The report shows how to identify that pattern, evaluate a scalable gut-brain care layer and test the economics on your own population.

81% vs 63%clinical response at program completion in Nerva's active-control IBS trial
71% vs 35%achieved at least a 30% reduction in abdominal pain in the same trial
4.7x modeledexpected gross ROI to test against a buyer's own claims data

Inside the report.

01
Where functional GI conditions can hide across repeat episodes of care.
02
A directional claims scan that supports clinical screening rather than replacing it.
03
The active-control evidence behind Nerva and its limits.
04
A transparent economic model that separates expected outputs from observed claims results.
05
How to structure a measurable health plan or employer pilot.

Bring a measurable functional GI pilot to your population.

For health plans For employers

Report · Health plans & employers · August 2026

Find the functional GI care gap hiding in repeat care.

81% vs 63%clinical response at program completion in Nerva's active-control IBS trial
71% vs 35%achieved at least a 30% reduction in abdominal pain in the same trial
4.7x modeledexpected gross ROI to test against a buyer's own claims data

Inside the report.

01
Where functional GI conditions can hide across repeat episodes of care.
02
A directional claims scan that supports clinical screening rather than replacing it.
03
The active-control evidence behind Nerva and its limits.
04
A transparent economic model that separates expected outputs from observed claims results.
05
How to structure a measurable health plan or employer pilot.

Bring a measurable functional GI pilot to your population.

For health plans For employers